SCHEMBL22303485

SCHEMBL22303485

CC(Cc1nc2ccccc2o1)c1ccc(OCc2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.40
▸ MAOA P21397 2/20 0.40
▸ MAOB P27338 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ MTNR1A P48039 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304368 0.77 NPC1 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL683906 0.73 ALOX5 (0.57) MAOAMAOBRAB9ASMN1; SMN2ALOX5
SCHEMBL20865042 0.73 SIGMAR1 (0.42) MAOAMAOBMEN1KMT2ACYP3A4
SCHEMBL20865070 0.72 KDM6B (0.46) NPC1RAB9ASMN1; SMN2HTTLMNA
SCHEMBL29783448 0.72 KDM6B (0.46) NPC1RAB9ASMN1; SMN2HTTLMNA
SCHEMBL20865040 0.72 CYP4F2 (0.48) MAOBALOX5LMNA
SCHEMBL22738331 0.72 F2RL3 (0.55) NPC1MAOAMAOBRAB9AMEN1
SCHEMBL31166963 0.71 ALOX5 (0.50) MAOAMAOBRAB9AKMT2ASMN1; SMN2
SCHEMBL20865074 0.71 PTGER1 (0.55) MAOBKMT2ASMN1; SMN2LMNAL3MBTL1
SCHEMBL20865038 0.71 MAOB (0.46) NPC1MAOAMAOBRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200246240-A1 RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE L'OREAL (FR) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200246240-A1 RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE KRT18, RARA, RBP4 NPC1 1249/4885MAOA 634/4885MAOB 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback